CD4 and inflammatory bowel disease: Secondly, for five diseases (IBD shared, JIA, PBC, PS (α < 0.01); RA (α < 0.05)) enrichment was observed for all four CD4+ T-cell subsets tested (Figure S6B in Additional file 11).